Hero Eco Med Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.00 Cr
as on 16-11-2024
- Revenue 16.95%
(FY 2023)
- Profit -5422.46%
(FY 2023)
- Ebitda -6188.05%
(FY 2023)
- Net Worth -4166.46%
(FY 2023)
- Total Assets 26.52%
(FY 2023)
About Hero Eco Med
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹8.00 Cr.
Vijay Munjal, Gaurav Munjal, and Vandana Munjal serve as directors at the Company.
- CIN/LLPIN
U33110DL2011PTC226707
- Company No.
226707
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Hero Eco Med?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Munjal  | Director | 24-Oct-2011 | Current |
| Gaurav Munjal | Director | 24-Oct-2011 | Current |
| Vandana Munjal | Director | 20-Jan-2022 | Current |
Financial Performance of Hero Eco Med.
Hero Eco Med Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.95% increase. The company also saw a substantial fall in profitability, with a 5422.46% decrease in profit. The company's net worth observed a substantial decline by a decrease of 4166.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hero Eco Med?
In 2023, Hero Eco Med had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kross Bikes Private LimitedActive 11 years 2 monthsVijay Munjal and Gaurav Munjal are mutual person
- Fairwell Engineers Private LimitedActive 17 years 6 months
Vijay Munjal and Gaurav Munjal are mutual person
- Mediva Health Care Private LimitedActive 13 years 3 months
Vijay Munjal and Gaurav Munjal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 03 Feb 2023 | ₹8.00 Cr | Open |
How Many Employees Work at Hero Eco Med?
Hero Eco Med has a workforce of 42 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hero Eco Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hero Eco Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
